相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Reversal of neuromuscular block
A. Srivastava et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Preclinical pharmacology of sugammadex
Anton Bom et al.
JOURNAL OF CRITICAL CARE (2009)
Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
The neuromuscular effects of 0.6 mg kg-1 rocuronium in elderly and young adults with or without renal failure
S. Kocabas et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2008)
Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision
T. Fuchs-Buder et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2007)
Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex - A multicenter, dosefinding and safety study
Hans D. de Boer et al.
ANESTHESIOLOGY (2007)
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
Harald J. Sparr et al.
ANESTHESIOLOGY (2007)
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex - A dose-finding and safety study
IF Sorgenfrei et al.
ANESTHESIOLOGY (2006)
Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys
HD de Boer et al.
ANESTHESIOLOGY (2006)
First human exposure of org 25969, a novel agent to reverse the action of rocuronium bromide
F Gijsenbergh et al.
ANESTHESIOLOGY (2005)
Urinary, biliary and faecal excretion of rocuronium in humans
JH Proost et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)